logo
logo

Medical 21 Secures Up To $20 Million Commitment For Its Pioneering Cardiac Bypass Technology

Sep 20, 2022•almost 3 years ago

Amount Raised

$20 Million

MinneapolisBiotechnology

Description

Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended, to implement its business plan.

Company Information

Company

Medical 21

Location

15070 23RD AVENUE NORTH

Minneapolis, Minnesota, United States

About

Medical 21, Inc. is a developmental stage medical device company founded by Dr. Manny Villafaña and located in Minneapolis, MN. We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People